Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Scientists search for clues in blood to predict transplant rejection therapy success

NCT ID NCT07316829

Summary

This study aims to understand why some transplant patients respond better than others to a light-based blood treatment (ECP) for chronic organ rejection. Researchers will analyze blood samples from 30 kidney or lung transplant patients to look for patterns in gene activity. The goal is to learn more about how the treatment works and potentially identify markers to predict who will benefit most.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRONCHIOLITIS OBLITERANS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Fondazione IRCCS Policlinico San Matteo di Pavia

    Pavia, Pavia, 27100, Italy

Conditions

Explore the condition pages connected to this study.